Investigator's Choice of Chemotherapy: clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
6
Conditions studied
30
US states with sites
21
Countries
Phase breakdown
Phase 3 2
Conditions being studied
| Condition | Trials |
|---|---|
| Breast cancer | 1 |
| Metastatic Breast Cancer | 1 |
| Mutation | 1 |
| Pancreatic cancer | 1 |
| Solid Tumors | 1 |
| Triple Negative Breast Cancer | 1 |
Recruiting trials involving Investigator's Choice of Chemotherapy
- A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
- Everolimus With Investigator's Choice of Chemotherapy in Advanced Triple-Negative Breast Cancer (TNBC) With Luminal Androgen Receptor (LAR) Subtype
Common questions
How many recruiting trials involve Investigator's Choice of Chemotherapy?
2 recruiting trials across 6 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.